Kalkine has a fully transformed New Avatar.
Last update at 2025-06-06T06:11:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Mach7 Technologies Limited's (ASX:M7T) Intrinsic Value Is Potentially 52% Above Its Share Price
Sun 21 May 23, 11:15 PMMach7 Technologies (ASX:M7T) Is In A Strong Position To Grow Its Business
Wed 19 Apr 23, 09:03 PMWhy Mach7 Technologies Limited (ASX:M7T) Could Be Worth Watching
Wed 05 Apr 23, 08:48 PMMach7 Technologies recognized as a top performer in the 2023 Best in KLAS Report
Mon 13 Feb 23, 06:30 PMBreakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
Income before tax | -6.65568M | -6.33445M | -11.63484M | -0.59469M | -7.82271M |
Minority interest | - | - | - | - | - |
Net income | -1.04811M | -4.16785M | -9.35720M | 0.17M | -7.05873M |
Selling general administrative | 27.40M | 23.81M | 19.13M | 11.44M | 9.91M |
Selling and marketing expenses | 0.76M | 0.69M | 0.14M | 0.36M | 0.53M |
Gross profit | 29.06M | 26.12M | 18.44M | 6.25M | -0.85924M |
Reconciled depreciation | 8.68M | 9.08M | 9.76M | 3.87M | 3.71M |
Ebit | -17.16713M | -6.27920M | -11.32224M | -0.52895M | -7.44454M |
Ebitda | -8.48630M | 2.80M | -1.55991M | 3.34M | -3.73731M |
Depreciation and amortization | 8.68M | 9.08M | 9.76M | 3.87M | 3.71M |
Non operating income net other | - | - | - | - | - |
Operating income | -7.37551M | -7.03516M | -10.73674M | -0.81919M | -7.39555M |
Other operating expenses | 6.90M | 7.03M | 2.16M | 5.57M | 3.26M |
Interest expense | 0.05M | 0.06M | 0.05M | 0.04M | 0.05M |
Tax provision | -5.60757M | -2.16660M | -2.27765M | -0.76398M | -0.76398M |
Interest income | 0.71M | 0.70M | 1.12M | 0.25M | 0.09M |
Net interest income | 0.33M | -0.02828M | -0.00657M | -0.04369M | -0.01758M |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | -5.60757M | -2.16660M | -2.27765M | -0.76398M | -0.76398M |
Total revenue | 30.05M | 27.08M | 19.03M | 18.86M | 9.35M |
Total operating expenses | 37.43M | 34.12M | 29.50M | 19.77M | 16.85M |
Cost of revenue | 0.99M | 0.96M | 0.59M | 12.61M | 10.21M |
Total other income expense net | 10.18M | 9.20M | -1.15753M | 0.19M | -0.30121M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | -1.04811M | -4.16785M | -9.35720M | 0.17M | -7.05873M |
Net income applicable to common shares | -1.04811M | -4.16785M | -9.35720M | 0.17M | -7.05873M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
Total assets | 73.03M | 82.31M | 78.92M | 76.97M | 61.62M |
Intangible assets | - | 31.11M | 39.01M | 45.76M | 6.94M |
Earning assets | - | - | - | - | - |
Other current assets | 0.92M | 4.16M | 4.04M | 3.97M | 2.91M |
Total liab | 21.17M | 22.82M | 20.55M | 19.05M | 8.15M |
Total stockholder equity | 51.86M | 59.48M | 58.38M | 57.91M | 53.47M |
Deferred long term liab | - | - | - | - | - |
Other current liab | 2.46M | 2.66M | 2.44M | 1.39M | 2.14M |
Common stock | 116.24M | 115.70M | 115.30M | 113.75M | 101.79M |
Capital stock | - | 115.70M | 115.30M | 113.75M | 101.79M |
Retained earnings | -71.00547M | -63.52575M | -63.49543M | -61.32982M | -51.97263M |
Other liab | - | 7.00M | 9.02M | 10.76M | 1.44M |
Good will | 4.19M | 4.35M | 4.30M | 4.10M | 4.10M |
Other assets | - | 4.95M | 1.34M | 1.25M | 0.76M |
Cash | 26.18M | 23.39M | 25.75M | 18.36M | 48.87M |
Cash and equivalents | - | 16.08M | 18.32M | 10.41M | 19.32M |
Total current liabilities | 15.09M | 14.83M | 10.39M | 7.49M | 6.53M |
Current deferred revenue | 11.63M | 11.22M | 7.03M | 5.58M | 2.78M |
Net debt | -24.90713M | -22.19392M | -24.42125M | -17.28527M | -48.55373M |
Short term debt | 0.18M | 0.21M | 0.19M | 0.27M | 0.13M |
Short long term debt | - | - | - | - | 0.13M |
Short long term debt total | 1.27M | 1.20M | 1.33M | 1.08M | 0.32M |
Other stockholder equity | - | -52.17134M | -51.80001M | -52.41642M | -49.81937M |
Property plant equipment | - | 2.00M | 2.07M | 1.45M | 0.49M |
Total current assets | 33.27M | 34.89M | 32.20M | 24.40M | 53.42M |
Long term investments | - | - | - | - | - |
Net tangible assets | - | 24.02M | 15.06M | 8.05M | 46.52M |
Short term investments | - | - | - | 0.03M | 0.02M |
Net receivables | 6.17M | 6.71M | 2.00M | 2.07M | 1.64M |
Long term debt | - | - | - | - | - |
Inventory | - | 0.63M | 0.42M | - | - |
Accounts payable | 0.82M | 0.74M | 0.72M | 0.25M | 1.47M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | 6.62M | 7.31M | 6.58M | 5.50M | 3.65M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | - | - | - | 101.79M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | - | - | - | - |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 25.02M | 5.80M | 0.76M | 0.70M | 0.76M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 39.76M | 47.42M | 46.72M | 52.57M | 8.20M |
Capital lease obligations | - | 1.20M | 1.33M | 1.08M | 0.32M |
Long term debt total | - | 0.99M | 1.14M | 0.80M | 0.19M |
Breakdown | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
Investments | -0.39131M | -0.36101M | -0.43856M | -42.33336M | -0.07946M |
Change to liabilities | - | 4.42M | 2.97M | 1.41M | 1.80M |
Total cashflows from investing activities | - | -0.36101M | -0.43856M | -42.33336M | -0.07946M |
Net borrowings | - | -0.25387M | -0.41011M | -0.29074M | -0.77377M |
Total cash from financing activities | -0.03208M | -0.06863M | 0.55M | 11.21M | 41.90M |
Change to operating activities | - | -5.45350M | -0.55217M | -1.64018M | -1.13987M |
Net income | -7.97032M | -1.04811M | -4.16785M | -9.35720M | 0.17M |
Change in cash | 2.78M | -2.35304M | 24.85M | 19.25M | 46.61M |
Begin period cash flow | 23.39M | 25.75M | 0.90M | -0.88397M | 2.27M |
End period cash flow | 26.18M | 23.39M | 25.75M | 18.36M | 48.87M |
Total cash from operating activities | 3.45M | -2.61205M | 6.37M | 1.50M | 4.75M |
Issuance of capital stock | 0.19M | 0.19M | 0.96M | 12.03M | 45.07M |
Depreciation | 7.25M | 1.17M | 1.31M | 2.47M | 2.10M |
Other cashflows from investing activities | -0.24404M | - | 0.00000M | -42.23366M | -0.00240M |
Dividends paid | - | - | - | 0.29M | - |
Change to inventory | - | 1.03M | -2.42223M | -0.97686M | -0.79080M |
Change to account receivables | 3.13M | -4.62709M | 0.08M | -0.43271M | 0.25M |
Sale purchase of stock | - | - | 0.96M | -0.52804M | -2.39091M |
Other cashflows from financing activities | -0.21957M | -0.25387M | -0.41011M | -0.29074M | -0.13796M |
Change to netincome | - | -4.58872M | -1.03190M | 1.76M | -0.19927M |
Capital expenditures | 0.15M | 0.36M | 0.44M | 0.10M | 0.08M |
Change receivables | - | - | - | - | - |
Cash flows other operating | - | - | - | - | - |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | - | - | - | - | - |
Change in working capital | 4.22M | -4.62709M | 0.08M | -0.43271M | 0.25M |
Stock based compensation | 1.27M | 1.08M | 1.70M | 1.93M | 0.70M |
Other non cash items | -1.32289M | -2.73606M | 9.23M | 8.38M | 2.48M |
Free cash flow | 3.30M | -2.97305M | 5.94M | 1.40M | 4.67M |
Sector: Healthcare Industry: Health Information Services
Company | Change (AUD) | Price (AUD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
M7T Mach7 Technologies Ltd |
-0.02 5.41% | 0.35 | - | - | 2.66 | 1.71 | 3.09 | 41.71 |
PME Pro Medicus Ltd |
-4.79 1.71% | 276.03 | 301.96 | 166.67 | 158.93 | 133.17 | 159.43 | 209.48 |
CGS CogState Ltd |
-0.01 0.77% | 1.29 | 18.57 | 19.34 | 4.65 | 3.19 | 2.25 | 8.27 |
ONE Oneview Healthcare PLC |
- -% | 0.27 | - | - | 21.55 | 9.14 | 10.96 | -3.5247 |
ALC Alcidion Group Ltd |
0.001 1.08% | 0.09 | - | 3.05 | 3.50 | 1.46 | 3.33 | 53.70 |
Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability for healthcare enterprises in North America, the Asia Pacific, the Middle East, Europe, and internationally. It offers enterprise diagnostic viewing, which include eUnity, zero-footprint viewing and vendor independent integration platform; and enterprise data management solutions that enable cross-department and cross-enterprise workflows to capture, index, manage, store, distribute, view, exchange, and analyze clinical imaging and multimedia content. The company also provides Enterprise PACS, an enterprise-ready imaging platform; and professional services, such as training and project management, clinical applications, and support and maintenance services. Mach7 Technologies Limited was founded in 2007 and is headquartered in South Burlington, Vermont.
120 Kimball Avenue, South Burlington, VT, United States, 05403
Name | Title | Year Born |
---|---|---|
Mr. Michael Lampron | CEO, MD & Director | NA |
Mr. Steven Parkes | Global Chief Financial Officer | NA |
Rebecca Thompson | Head of Investor Relations | NA |
Mr. Bob Tranchida | VP of Marketing | NA |
Mr. David Madaffri | Exec. VP | NA |
Ms. Veronique Morgan-Smith | Company Sec. | NA |
Mr. David Madaffri | Chief Operating Officer | NA |
Francoise Dixon | Head of Investor Relations | NA |
Mr. Bob Tranchida | Vice President of Marketing | NA |
Ms. Dyan O'Herne | Chief Financial Officer | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.